Medivation

Exondys Sales, Takeover Speculation Fuel Sarepta Therapeutics

Analysts Prescribe A Downgrade For Pfizer Stock

5-Month Timeline: A Look Back At Medivation's Takeover Story

Analysts Prescribe A Downgrade For Pfizer Stock

5-Month Timeline: A Look Back At Medivation's Takeover Story

Short-Sellers Shy Away From These 2 Biotechs This Settlement Period

Biotech In The Earnings Spotlight: Amgen, Celgene, Gilead Sciences

Short-Sellers Shy Away From These 2 Biotechs This Settlement Period

Biotech In The Earnings Spotlight: Amgen, Celgene, Gilead Sciences

Biogen And Gilead Sciences Buck Biotech Short Interest Trend

Sanofi Names Candidates, Committed To Replacing Medivation's Entire Board

Medivation Recent News

Short Interest Surges In Illumina And Vertex Pharmaceuticals

Short Sellers Dump Amgen And Baxalta

Here's What Medivation Said In Its Rejection Letter To Sanofi

Sanofi Wants To Acquire Medivation For $52.50 Per Share

Short Sellers Dump Vertex, Load Up On Baxalta

Medivation Ticks Up 3%, AstraZeneca Said To Be Also Interested In Acquisition

Medivation Drops 12% After Congress Asks To Examine Xtandi Drug Price

More Wild Short Interest Swings In Biotech Stocks

Wild Short Interest Swings For Three Top Biotech Stocks

3 Biotech Stocks With Rising Short Interest

Citigroup Adds Tesaro To 'Focus List,' Removes Medivation

3 More Surges In Biotech Short Interest (AMGN, MDVN, PCYC)

Surges In Biotech Short Interest (INCY, PCYC, REGN)

Short Interest Rises As Biotechs Fall (AMGN, CELG, DNDN)

Celgene, Pharmacyclics Lead Biotech Short Interest Trend (CELG, MDVN, PCYC)

BioMarin, Medivation Buck Biotech Short Interest Trend (BIIB, BMRN, MDVN)

Market Wrap For February 28: Markets Unable To Hold On To Gains

Amgen, BioMarin Lead Biotech Short Interest Trend (AMGN, BIIB, BMRN)

BioMarin Bucks Biotech Short Interest Trend (BIIB, BMRN, MDVN)

New Year Short Interest Swings In Biotech (BIIB, BMRN, MDVN)

Celgene, Dendreon Lead Short Interest Trend In Biotechs (BMRN, CELG, DNDN)

Rising Short Interest In Pharmacyclics, Other Biotechs (AMGN, GILD, PCYC)

Three Biotech Stocks Analysts Are Keen On (MDVN, GEVA, OPTR)